Carine M Boustany-Kari Selected Research

Hyperkalemia

1/2013	PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy.
10/2011	The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carine M Boustany-Kari Research Topics

Disease

5	Diabetic Nephropathies (Diabetic Nephropathy) 10/2019 - 10/2011
4	Disease Progression 01/2023 - 03/2016
3	Chronic Renal Insufficiency 01/2023 - 11/2018
2	Kidney Diseases (Kidney Disease) 12/2022 - 10/2021
2	Fibrosis (Cirrhosis) 10/2021 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2011
2	Hyperkalemia 01/2013 - 10/2011
2	Obesity 06/2012 - 05/2011
1	Proteinuria 01/2023
1	Sclerosis 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2022
1	Albuminuria 10/2021
1	Bites and Stings (Sting) 10/2021
1	Non-alcoholic Fatty Liver Disease 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Hypertension (High Blood Pressure) 06/2012
1	Weight Loss (Weight Reduction) 05/2011
1	Body Weight (Weight, Body) 05/2011

Drug/Important Bio-Agent (IBA)

2	Soluble Guanylyl CyclaseIBA 01/2023 - 03/2016
2	CollagenIBA 10/2019 - 01/2013
2	CreatinineIBA 01/2019 - 01/2018
2	AlbuminsIBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2014
1	Enalapril FDA LinkGeneric 01/2023
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Interleukin-11 (Interleukin 11)IBA 12/2022
1	Disulfiram (Antabuse)FDA Link 10/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2021
1	Apolipoprotein L1IBA 10/2021
1	InflammasomesIBA 10/2021
1	InterferonsIBA 10/2021
1	NucleotidesIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Losartan (Cozaar)FDA LinkGeneric 01/2019
1	Waste Products (Waste Product)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	Mineralocorticoid Receptor AntagonistsIBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acidIBA 01/2013
1	Eplerenone (Inspra)FDA LinkGeneric 01/2013
1	AldosteroneIBA 01/2013
1	Gonadal Steroid Hormones (Sex Hormones)IBA 06/2012
1	Angiotensin-Converting Enzyme 2IBA 06/2012
1	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2011
1	Glucose (Dextrose)FDA LinkGeneric 12/2011
1	SodiumIBA 12/2011
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2011
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2011
1	LeptinIBA 05/2011
1	RimonabantIBA 05/2011
1	CannabinoidsIBA 05/2011

Therapy/Procedure

3	Therapeutics 12/2022 - 05/2011
1	Ovariectomy (Oophorectomy) 06/2012